Tag: genomics
-
Alphabet Forms AI Drug Discovery Company
Alphabet, the parent company of Google, is forming a new enterprise using artificial intelligence techniques to discover new protein-based drugs.
-
Cell Therapy Biotech Raises $75.5M in Venture Funds
A developer of off-the-shelf genetically engineered platelet cells to treat a range of diseases is raising $75.5 million in its second venture round.
-
Synthetic Protein Company Gains $25M in New Funds
A company designing engineered proteins to work better than natural chemistries as treatments for disease is raising $25 million in its first venture round.
-
AI Analysis Finds Serious Covid-19 Genetic Driver
A deep and multi-variable analysis of patients with serious Covid-19 respiratory symptoms finds the condition associated with abnormal expression of one gene.
-
Population Study Finds Genetic Links for Vertigo
A large-scale population genetics study finds several genetic variants associated with vertigo, a condition marked by dizziness and loss of balance.
-
Crispr Licensed for Eye Disease Gene Therapies
A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes.
-
FDA Halts Off-the-Shelf T-Cell Cancer Trials
The Food and Drug Administration stopped a company’s clinical trials of off-the-shelf engineered T-cells after a patient showed an abnormal chromosomal reaction.
-
Precision Neuroscience Company Starts-Up, Raises $500M
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science.
-
Elephant Genetic Codes to be Sequenced, Preserved
A biotechnology company using gene editing to preserve animal species is sequencing the genomes of three elephant varieties to help prevent their extinction.
-
Genomic Analysis Shown to Detect Early Pancreatic Cancer
Analysis of genomic and protein indicators in blood samples is shown to detect pancreatic cancer in earlier stages, increasing chances of survival.